These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38387090)

  • 1. Oral Delivery of the Vancomycin Derivative FU002 by a Surface-Modified Liposomal Nanocarrier.
    Werner J; Umstätter F; Hertlein T; Mühlberg E; Beijer B; Wohlfart S; Zimmermann S; Haberkorn U; Ohlsen K; Fricker G; Mier W; Uhl P
    Adv Healthc Mater; 2024 Jun; 13(14):e2303654. PubMed ID: 38387090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved pharmacokinetics and enhanced efficacy of the vancomycin derivative FU002 using a liposomal nanocarrier.
    Werner J; Umstätter F; Hertlein T; Beijer B; Kleist C; Mühlberg E; Zimmermann S; Haberkorn U; Ohlsen K; Fricker G; Mier W; Uhl P
    Nanomedicine; 2024 Feb; 56():102731. PubMed ID: 38158147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral delivery of vancomycin by tetraether lipid liposomes.
    Uhl P; Pantze S; Storck P; Parmentier J; Witzigmann D; Hofhaus G; Huwyler J; Mier W; Fricker G
    Eur J Pharm Sci; 2017 Oct; 108():111-118. PubMed ID: 28716758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and evaluation of a folic acid receptor-targeted oral vancomycin liposomal dosage form.
    Anderson KE; Eliot LA; Stevenson BR; Rogers JA
    Pharm Res; 2001 Mar; 18(3):316-22. PubMed ID: 11442271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin Resistance Is Overcome by Conjugation of Polycationic Peptides.
    Umstätter F; Domhan C; Hertlein T; Ohlsen K; Mühlberg E; Kleist C; Zimmermann S; Beijer B; Klika KD; Haberkorn U; Mier W; Uhl P
    Angew Chem Int Ed Engl; 2020 Jun; 59(23):8823-8827. PubMed ID: 32190958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Engineering mesoporous silica nanoparticles towards oral delivery of vancomycin.
    Ndayishimiye J; Cao Y; Kumeria T; Blaskovich MAT; Falconer JR; Popat A
    J Mater Chem B; 2021 Sep; 9(35):7145-7166. PubMed ID: 34525166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Liposomal encapsulation of vancomycin improves killing of methicillin-resistant Staphylococcus aureus in a murine infection model.
    Sande L; Sanchez M; Montes J; Wolf AJ; Morgan MA; Omri A; Liu GY
    J Antimicrob Chemother; 2012 Sep; 67(9):2191-4. PubMed ID: 22661572
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overcoming multiple gastrointestinal barriers by bilayer modified hollow mesoporous silica nanocarriers.
    Wang Y; Zhao Y; Cui Y; Zhao Q; Zhang Q; Musetti S; Kinghorn KA; Wang S
    Acta Biomater; 2018 Jan; 65():405-416. PubMed ID: 29037897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An efficient PEGylated liposomal nanocarrier containing cell-penetrating peptide and pH-sensitive hydrazone bond for enhancing tumor-targeted drug delivery.
    Ding Y; Sun D; Wang GL; Yang HG; Xu HF; Chen JH; Xie Y; Wang ZQ
    Int J Nanomedicine; 2015; 10():6199-214. PubMed ID: 26491292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Daptomycin Proliposomes for Oral Delivery: Formulation, Characterization, and In Vivo Pharmacokinetics.
    Arregui JR; Kovvasu SP; Betageri GV
    AAPS PharmSciTech; 2018 May; 19(4):1802-1809. PubMed ID: 29616488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.
    Al Asmari AK; Ullah Z; Tariq M; Fatani A
    Drug Des Devel Ther; 2016; 10():205-15. PubMed ID: 26834457
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral peptide delivery by tetraether lipid liposomes.
    Parmentier J; Thewes B; Gropp F; Fricker G
    Int J Pharm; 2011 Aug; 415(1-2):150-7. PubMed ID: 21664955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation of liposomal vancomycin and intracellular killing of meticillin-resistant Staphylococcus aureus (MRSA).
    Pumerantz A; Muppidi K; Agnihotri S; Guerra C; Venketaraman V; Wang J; Betageri G
    Int J Antimicrob Agents; 2011 Feb; 37(2):140-4. PubMed ID: 21130608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved transport and absorption through gastrointestinal tract by PEGylated solid lipid nanoparticles.
    Yuan H; Chen CY; Chai GH; Du YZ; Hu FQ
    Mol Pharm; 2013 May; 10(5):1865-73. PubMed ID: 23495754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Labrasol-Enriched Nanoliposomal Formulation: Novel Approach to Improve Oral Absorption of Water-Insoluble Drug, Carvedilol.
    Ghassemi S; Haeri A; Shahhosseini S; Dadashzadeh S
    AAPS PharmSciTech; 2018 Oct; 19(7):2961-2970. PubMed ID: 30030724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel two-chain fatty acid-based lipids for development of vancomycin pH-responsive liposomes against
    Makhathini SS; Kalhapure RS; Jadhav M; Waddad AY; Gannimani R; Omolo CA; Rambharose S; Mocktar C; Govender T
    J Drug Target; 2019 Dec; 27(10):1094-1107. PubMed ID: 30901236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular uptake and
    Subramaniam S; Joyce P; Conn CE; Prestidge CA
    Biomater Sci; 2024 Jun; 12(13):3411-3422. PubMed ID: 38809118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced oral bioavailability of insulin using PLGA nanoparticles co-modified with cell-penetrating peptides and Engrailed secretion peptide (Sec).
    Zhu S; Chen S; Gao Y; Guo F; Li F; Xie B; Zhou J; Zhong H
    Drug Deliv; 2016 Jul; 23(6):1980-91. PubMed ID: 26181841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
    Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
    Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fabrication of solid lipid nanoparticles of lurasidone HCl for oral delivery: optimization,
    Patel MH; Mundada VP; Sawant KK
    Drug Dev Ind Pharm; 2019 Aug; 45(8):1242-1257. PubMed ID: 30880488
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.